Horizon Technology Finance led a $30 million venture loan facility for TemperPack Technologies, a manufacturer of sustainable insulated packaging for perishable last mile deliveries.
Horizon Technology Finance Management entered into an agreement with Waterfall Asset Management to originate and manage a venture debt portfolio. Horizon will originate and manage an initial commitment of $100 million, with the potential to increase to $300 million over time.
Horizon Technology Finance provided a $9 million venture loan facility to InfoBionic, of which $7 million has been initially funded.
Horizon Technology Finance provided a $9 million venture loan facility to Primary Kids, of which $6 million has been initially funded. Primary Kids will use the loan proceeds for general growth and working capital purposes.
Horizon Technology Finance provided a $5 million venture loan to Corinth MedTech, a medical device company that recently developed the Veloxion System, an FDA-cleared device for treating symptoms related to benign prostatic hyperplasia.
Horizon Technology Finance and Emalex Biosciences announced a $15 million venture loan facility to advance Emalex’s development programs through clinical trials.
LogicBio Therapeutics closed a $20 million secured debt facility with Oxford Finance and Horizon Technology Finance.
Horizon Technology Finance provided a $5 million venture loan facility to Meditrina, of which $3 million has been initially funded.
Horizon Technology Finance, a specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, has provided a $20 million venture loan facility to Encore Dermatology, of which $15 million has been initially funded.
Catasys, an AI and technology-enabled healthcare company, amended and expanded its receivable facility agreement and term loan with Horizon Technology Finance to $15 million.